Evaluation of impact of one dose varicella vaccine on the incidence of chickenpox in Argentina.
作者： Guillermo G. Barrenechea , Leonardo S. Bastos
DOI: 10.1016/J.VACCINE.2019.10.003
关键词:
摘要: Summary Introduction Varicella, also known as chickenpox is one of the most common immunizable diseases. In 1998, World Health Organization (WHO) recommended to incorporate this vaccine in national immunization programs, which Argentina did 2015. Objectives To describe behavior varicella time series for 2005–2017 period, and evaluate impact Argentina. Methodology An ecological observational study was performed, using cases reported National Monitoring System, data census secondary sources. A model based analysis notified a Negative Binomial Mixed Model. For verification impact, 2005–2014 period selected, prognosis following years performed. Impact evaluated by comparing rates confidence intervals between predicted observed values. Results 1,775,587 period. The exhibited seasonality, and, decreasing trend number 2016 2017. reduction incidence rate after implementation observed. transmission risk decreased country implementation. Conclusions This first concrete evidence decline single dose application program
lshtm.ac.uk
sci-hub.se 参考文章(47)
Tetsushi Yoshikawa, Yoshiki Kawamura, Masahiro Ohashi, Universal varicella vaccine immunization in Japan. Vaccine. ,vol. 34, pp. 1965- 1970 ,(2016) , 10.1016/J.VACCINE.2016.02.058
D. Perella, C. Wang, R. Civen, K. Viner, K. Kuguru, I. Daskalaki, D. S. Schmid, A. S. Lopez, H. F. Tseng, E. C. Newbern, L. Mascola, S. R. Bialek, Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era. Pediatrics. ,vol. 137, ,(2016) , 10.1542/PEDS.2015-2802
Ariel Bardach, María Luisa Cafferata, Karen Klein, Gabriela Cormick, Luz Gibbons, Silvina Ruvinsky, Incidence and Use of Resources for Chickenpox and Herpes Zoster in Latin America and the Caribbean—A Systematic Review and Meta-analysis The Pediatric Infectious Disease Journal. ,vol. 31, pp. 1263- 1268 ,(2012) , 10.1097/INF.0B013E31826FF3A5
Michiaki Takahashi, The varicella vaccine. Vaccine development Infectious Disease Clinics of North America. ,vol. 10, pp. 469- 488 ,(1996) , 10.1016/S0891-5520(05)70309-3
María L. Avila-Aguero, Rolando Ulloa-Gutierrez, Kattia Camacho-Badilla, Alejandra Soriano-Fallas, Roberto Arroba-Tijerino, Ana Morice-Trejos, Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination Expert Review of Vaccines. ,vol. 16, pp. 229- 234 ,(2017) , 10.1080/14760584.2017.1247700
Isabella Marinelli, Alies van Lier, Hester de Melker, Andrea Pugliese, Michiel van Boven, Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus. Epidemics. ,vol. 19, pp. 1- 12 ,(2017) , 10.1016/J.EPIDEM.2016.11.001
M. Eugenia Estrada Fernández, Ana I. Gil Lacruz, Marta Gil Lacruz, Antonio Viñas López, La dependencia: efectos en la salud familiar Atencion Primaria. ,vol. 50, pp. 23- 34 ,(2017) , 10.1016/J.APRIM.2016.12.007
Luis García Comas, Pello Latasa Zamalloa, Guadalupe Alemán Vega, María Ordobás Gavín, Araceli Arce Arnáez, Inmaculada Rodero Garduño, Alicia Estirado Gómez, Ester Insúa Marisquerena, Descenso de la incidencia de la varicela en la Comunidad de Madrid tras la vacunación infantil universal. Años 2001-2015 Atencion Primaria. ,vol. 50, pp. 53- 59 ,(2017) , 10.1016/J.APRIM.2017.01.010
Thorsten Rieck, Marcel Feig, Matthias an der Heiden, Anette Siedler, Ole Wichmann, Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Eurosurveillance. ,vol. 22, pp. 30521- ,(2017) , 10.2807/1560-7917.ES.2017.22.17.30521
Sarah L. Sheridan, Helen E. Quinn, Brynley P. Hull, Robert S. Ware, Keith Grimwood, Stephen B. Lambert, Impact and effectiveness of childhood varicella vaccine program in Queensland, Australia. Vaccine. ,vol. 35, pp. 3490- 3497 ,(2017) , 10.1016/J.VACCINE.2017.05.013